ArticleESMO gastrointestinal oncology2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.
D Okemoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.